Other languages PharmaCyte Biotech, Inc.

Equities

PMCB

US71715X2036

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-02 pm EDT			5-day change	1st Jan Change
2.06 ^USD	+5.10%		+1.48%	-4.63%

Jun. 17	MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc.	CI
May. 23	MyMD Pharmaceuticals, Inc. amended terms of the transaction	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

PharmaCyte Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Mar. 18
PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Dec. 15
PharmaCyte Biotech, Inc. Provides Corporate Update on Cell-In-A-Box Technology	23-10-31
PharmaCyte Biotech, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	23-09-18
PharmaCyte Biotech, Inc. Reports Earnings Results for the Full Year Ended April 30, 2023	23-07-31
PharmaCyte Biotech, Inc. announces an Equity Buyback for 7,750,000 shares, for $25.19 million.	23-05-11
PharmaCyte Biotech, Inc authorizes a Buyback Plan.	23-05-10
PharmaCyte Biotech, Inc. announces an Equity Buyback for $10 million worth of its shares.	23-02-02
PharmaCyte Biotech, Inc. authorizes a Buyback Plan.	23-01-30
PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	22-12-14
PharmaCyte Biotech, Inc. Announces Resignation of Jack E. Stover as Director	22-11-07
PharmaCyte Biotech, Inc. Announces Resignation of Gerald W. Crabtree as Chief Scientific Officer	22-10-14
PharmaCyte Biotech, Inc. Announces Management Changes	22-10-07
PharmaCyte Biotech CEO Kenneth Waggoner Resigns; Board Forms Business Review Committee; Shares Rise	22-10-07
PharmaCyte Biotech, Inc. Announces Management Changes	22-10-07
PharmaCyte Biotech, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2022	22-09-14
PharmaCyte Biotech Reaches Agreement With Iroquois to Appoint Two Directors to Board	22-08-15
PharmaCyte Biotech, Inc. Announces Board Appointments	22-08-15
PharmaCyte Biotech, Inc. Reports Earnings Results for the Full Year Ended April 30, 2022	22-07-28
PharmaCyte Biotech Issues a Statement in Response to Iroquois Capital’s Preliminary Consent Statement	22-07-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages PharmaCyte Biotech, Inc.

Equities

PMCB

US71715X2036

Other languages

Filters